Jiangsu Bioperfectus (China) Top Management
688399 Stock | 70.20 0.17 0.24% |
Jiangsu Bioperfectus employs about 684 people. The company is managed by 4 executives with a total tenure of roughly 1596 years, averaging almost 399.0 years of service per executive, having 171.0 employees per reported executive. Analysis of Jiangsu Bioperfectus' management performance can provide insight into the company performance.
Guoqiang Wang Chairman Chairman GM |
Jiangsu |
Jiangsu Bioperfectus Management Team Effectiveness
The company has return on total asset (ROA) of (0.0315) % which means that it has lost $0.0315 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0496) %, meaning that it generated substantial loss on money invested by shareholders. Jiangsu Bioperfectus' management efficiency ratios could be used to measure how well Jiangsu Bioperfectus manages its routine affairs as well as how well it operates its assets and liabilities. At present, Jiangsu Bioperfectus' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 31 M, whereas Total Assets are forecasted to decline to about 2.3 B.The current year's Net Income Applicable To Common Shares is expected to grow to about 2.2 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 59.9 M.
Jiangsu Bioperfectus Workforce Comparison
Jiangsu Bioperfectus Technologies is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 31,009. Jiangsu Bioperfectus holds roughly 684 in number of employees claiming about 2.21% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32. Jiangsu Bioperfectus Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Jiangsu Bioperfectus Price Series Summation is a cross summation of Jiangsu Bioperfectus price series and its benchmark/peer.
Jiangsu Bioperfectus Notable Stakeholders
A Jiangsu Bioperfectus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Jiangsu Bioperfectus often face trade-offs trying to please all of them. Jiangsu Bioperfectus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Jiangsu Bioperfectus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Guoqiang Wang | Chairman GM | Profile | |
Yuanyuan Hu | Deputy Directors | Profile | |
Zhonghua Liu | Technical GM | Profile | |
Haidong Shen | Deputy Center | Profile |
About Jiangsu Bioperfectus Management Performance
The success or failure of an entity such as Jiangsu Bioperfectus often depends on how effective the management is. Jiangsu Bioperfectus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Jiangsu management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Jiangsu management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Jiangsu Bioperfectus is entity of China. It is traded as Stock on SHG exchange.
Please note, the presentation of Jiangsu Bioperfectus' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Jiangsu Bioperfectus' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Jiangsu Bioperfectus' management manipulating its earnings.
Jiangsu Bioperfectus Workforce Analysis
Traditionally, organizations such as Jiangsu Bioperfectus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Jiangsu Bioperfectus within its industry.Jiangsu Bioperfectus Manpower Efficiency
Return on Jiangsu Bioperfectus Manpower
Revenue Per Employee | 589.4K | |
Revenue Per Executive | 100.8M | |
Net Loss Per Employee | 562K | |
Net Loss Per Executive | 96.1M | |
Working Capital Per Employee | 3.4M | |
Working Capital Per Executive | 586.5M |
Complementary Tools for Jiangsu Stock analysis
When running Jiangsu Bioperfectus' price analysis, check to measure Jiangsu Bioperfectus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu Bioperfectus is operating at the current time. Most of Jiangsu Bioperfectus' value examination focuses on studying past and present price action to predict the probability of Jiangsu Bioperfectus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu Bioperfectus' price. Additionally, you may evaluate how the addition of Jiangsu Bioperfectus to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |